Allogeneic Pancreatic Islet Cells

BIOLOGICAL6 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

Diabetes Mellitus, Type 1Diabetes Mellitus, Type IType 1 Diabetes Mellitus

Phase 2

Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes

CompletedNCT00434850

National Institute of Allergy and Infectious Diseases (NIAID)Diabetes Mellitus, Type 1

Start: 2006-10-31End: 2013-11-30Updated: 2016-03-16

LEA29Y (Belatacept) Emory Edmonton Protocol

CompletedNCT00468403

National Institute of Allergy and Infectious Diseases (NIAID)Type 1 Diabetes Mellitus

Start: 2008-10-31End: 2013-04-30Updated: 2016-04-07

B-Lymphocyte Immunotherapy in Islet Transplantation

TerminatedNCT00468442

National Institute of Allergy and Infectious Diseases (NIAID)Type 1 Diabetes Mellitus

Start: 2006-11-30End: 2011-09-30Updated: 2016-03-21

Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation After Kidney Transplant

WithdrawnNCT00790439

National Institute of Allergy and Infectious Diseases (NIAID)Diabetes Mellitus, Type I

Start: 2008-07-31End: 2009-10-31Updated: 2014-06-12

Phase 3

Islet Transplantation in Type 1 Diabetes

CompletedNCT00434811

National Institute of Allergy and Infectious Diseases (NIAID)Type 1 Diabetes Mellitus

Start: 2006-10-31End: 2014-05-31Updated: 2019-07-17

Unknown Phase

B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure

National Institute of Allergy and Infectious Diseases (NIAID)Type 1 Diabetes Mellitus

Updated: 2014-06-11

Related Papers

Identifying Promising Immunomodulators for Type 1 Diabetes (T1D) and Islet Transplantation.

2024-12-204 citations

Human Islet Cell Transplantation Successful in Patients with Type 1 Diabetes Who Have SH

MD Conference Express2014-07-01